• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[维拉帕米口服缓释制剂的研制及在麻醉犬体内的吸收研究]

[Development of an oral retard preparation of verapamil and absorption study in the anesthetized dog].

作者信息

Mayer D, Raschack M, Kesselring K

出版信息

Arzneimittelforschung. 1975 Aug;25(8):1272-5.

PMID:241362
Abstract
  1. An oral retard preparation of verapamil (Isoptin retard) is described. The sustained release of the active compound from verapamil retard is obtained by mixing and pressing verapamil hydrochloride with sodium alginate. The proportion of active compound and physiologically indifferent additive may range between 1:1 and 1:2. 2. The determination of the in vitro release according to the half-change method shows that verapamil is completely released from the retard preparation only after 6 to 7 h; with conventional dragées more than 90% of the compound is dissolved already after 10 min. 3. In artificial gastric and intestinal juice (pH 1.4 and 7.5) similar times of release are found. 4. The in vitro results are supported by tests on the intestinal absorption in the anesthetized dog. In a ligated duodenum section verapamil is, 3 to 8 h after application, markedly more slowly released and absorbed from the retard preparation than from conventional dragées.
摘要
  1. 描述了维拉帕米的一种缓释制剂(异搏定缓释片)。通过将盐酸维拉帕米与海藻酸钠混合并压制,可实现活性化合物从维拉帕米缓释制剂中的持续释放。活性化合物与生理惰性添加剂的比例范围可为1:1至1:2。2. 根据半量变化法测定体外释放表明,维拉帕米仅在6至7小时后才从缓释制剂中完全释放;而传统糖衣丸在10分钟后已有超过90%的化合物溶解。3. 在人工胃液和肠液(pH 1.4和7.5)中发现了相似的释放时间。4. 体外实验结果得到了在麻醉犬身上进行的肠道吸收试验的支持。在结扎的十二指肠段,给药后3至8小时,维拉帕米从缓释制剂中的释放和吸收明显比从传统糖衣丸中缓慢。

相似文献

1
[Development of an oral retard preparation of verapamil and absorption study in the anesthetized dog].[维拉帕米口服缓释制剂的研制及在麻醉犬体内的吸收研究]
Arzneimittelforschung. 1975 Aug;25(8):1272-5.
2
[Demonstration of the long term action of an oral retard preparation of verapamil in the conscious dog].[维拉帕米口服缓释制剂在清醒犬体内的长期作用演示]
Arzneimittelforschung. 1975 Aug;25(8):1275-8.
3
Use of an in vitro absorption model system for predicting sustained release of verapamil.使用体外吸收模型系统预测维拉帕米的缓释效果。
Arzneimittelforschung. 1992 Sep;42(9):1098-100.
4
Comparison of the pharmaceutical properties of sustained-release gel beads prepared by alginate having different molecular size with commercial sustained-release tablet.不同分子大小的藻酸盐制备的缓释凝胶珠与市售缓释片的药学性质比较。
Pharmazie. 2000 Mar;55(3):218-22.
5
Verapamil disposition and effect on PQ-intervals after buccal, oral and intravenous administration.维拉帕米经颊、口服和静脉给药后的处置及其对PQ间期的影响。
Arzneimittelforschung. 1984;34(4):498-502.
6
High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.用于口服缓释药物的高直链羧甲基淀粉基质:体外和体内评价
Eur J Pharm Biopharm. 2007 Mar;65(3):371-8. doi: 10.1016/j.ejpb.2006.12.001. Epub 2006 Dec 13.
7
Controlling of systemic absorption of gliclazide through incorporation into alginate beads.通过将格列齐特包埋于海藻酸钠微球中来控制其全身吸收。
Int J Pharm. 2007 Aug 16;341(1-2):230-7. doi: 10.1016/j.ijpharm.2007.03.047. Epub 2007 Apr 5.
8
[Preparation of verapamil hydrochloride core-in-cup tablets with double-pulsatile and multi-phasic release].[双脉冲多相释放盐酸维拉帕米杯形包芯片的制备]
Yao Xue Xue Bao. 2008 Jun;43(6):652-6.
9
[Development of an oral nitroglycerin proxyphyllin retard compound].
Arzneimittelforschung. 1970 Sep;20(9):1180-7.
10
[Effect of various factors on in vitro output velocity from delayed-action tablets 1. Tetracycline delayed-action tablets].[多种因素对缓释片体外释放速度的影响 1. 四环素缓释片]
Pharmazie. 1973 Jul;28(7):447-9.